Reducing body myopathy is a rare progressive myopathy identified by characteristic pathological findings and secondary to dominantly acting mutations in the X-linked FHL1 gene. We report muscle MRI findings in two patients affected by reducing body myopathy and in their carrier mothers. All four showed a distinctive pattern of muscle alteration, with a predominant involvement of postero-medial muscle at thigh level and of soleus at calf level, with a striking sparing of glutei muscles that also appeared to be hypertrophic. These findings may help in the differential diagnosis of these disorders
\ua9 2015 Elsevier B.V. Identifying the mutated gene that produces a particular muscle dystrophy is ...
Autosomal dominant limb girdle muscular dystrophy D3 HNRNPDL-related is a rare dominant myopathy cau...
International audienceBackground and objective Dysferlinopathies are a group of muscle disorders cau...
Reducing body myopathy is a rare progressive myopathy identified by characteristic pathological find...
Objective: FHL1-related reducing body myopathy is an ultra-rare, X-linked dominant myopathy. In this...
Introduction: Reducing body myopathy is a rare X-linked myopathy. It is characterized by intracytopl...
FHL1 mutations have been associated with various disorders that include reducing body myopathy (RBM)...
We describe the clinical and muscle MRI changes in 2 siblings with neutral lipid storage disease wit...
FHL1 mutations cause several clinically heterogeneous myopathies, including reducing body myopathy (...
Beta-tropomyosin 2 (TPM2) gene mutations are a rare cause of congenital myopathy with variable clini...
Background: Lipid storage myopathy (LSM) is a genetically heterogeneous group with variable clinical...
Limb girdle muscular dystrophy type 2I (LGMD2I) is an autosomal recessive muscular dystrophy that is...
Here we describe the first case of myotonic dystrophy type 1 (DM1) associated with facio–scapulo–hum...
Dysferlinopathies are a group of muscle disorders caused by mutations in the DYSF gene. Previous mus...
GNE myopathy (MIM 600737) is an autosomal recessive muscle disease caused by mutations in the UDP-N-...
\ua9 2015 Elsevier B.V. Identifying the mutated gene that produces a particular muscle dystrophy is ...
Autosomal dominant limb girdle muscular dystrophy D3 HNRNPDL-related is a rare dominant myopathy cau...
International audienceBackground and objective Dysferlinopathies are a group of muscle disorders cau...
Reducing body myopathy is a rare progressive myopathy identified by characteristic pathological find...
Objective: FHL1-related reducing body myopathy is an ultra-rare, X-linked dominant myopathy. In this...
Introduction: Reducing body myopathy is a rare X-linked myopathy. It is characterized by intracytopl...
FHL1 mutations have been associated with various disorders that include reducing body myopathy (RBM)...
We describe the clinical and muscle MRI changes in 2 siblings with neutral lipid storage disease wit...
FHL1 mutations cause several clinically heterogeneous myopathies, including reducing body myopathy (...
Beta-tropomyosin 2 (TPM2) gene mutations are a rare cause of congenital myopathy with variable clini...
Background: Lipid storage myopathy (LSM) is a genetically heterogeneous group with variable clinical...
Limb girdle muscular dystrophy type 2I (LGMD2I) is an autosomal recessive muscular dystrophy that is...
Here we describe the first case of myotonic dystrophy type 1 (DM1) associated with facio–scapulo–hum...
Dysferlinopathies are a group of muscle disorders caused by mutations in the DYSF gene. Previous mus...
GNE myopathy (MIM 600737) is an autosomal recessive muscle disease caused by mutations in the UDP-N-...
\ua9 2015 Elsevier B.V. Identifying the mutated gene that produces a particular muscle dystrophy is ...
Autosomal dominant limb girdle muscular dystrophy D3 HNRNPDL-related is a rare dominant myopathy cau...
International audienceBackground and objective Dysferlinopathies are a group of muscle disorders cau...